| FRESOLIMUMAB | Antibody | osteogenesis imperfecta | Transforming growth factor beta-1 inhibitor | 1.0 | Completed | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | breast adenocarcinoma | Transforming growth factor beta binding agent | 1.0 | Withdrawn | ClinicalTrials |
| FRESOLIMUMAB | Antibody | non-small cell lung carcinoma | Transforming growth factor beta-1 inhibitor | 1.0 | Completed | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | non-small cell lung carcinoma | Transforming growth factor beta binding agent | 2.0 | Terminated | ClinicalTrials |
| FRESOLIMUMAB | Antibody | focal segmental glomerulosclerosis | Transforming growth factor beta-1 inhibitor | 1.0 | Completed | ClinicalTrials |
| LUSPATERCEPT | Protein | myeloproliferative disorder | Transforming growth factor beta inhibitor | 3.0 | Recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | Thalassemia | Transforming growth factor beta inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | myelodysplastic syndrome | Transforming growth factor beta inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | non-small cell lung carcinoma | Transforming growth factor beta binding agent | 2.0 | Active, not recruiting | ClinicalTrials |
| FRESOLIMUMAB | Antibody | malignant pleural mesothelioma | Transforming growth factor beta-1 inhibitor | 2.0 | Completed | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | soft tissue sarcoma | Transforming growth factor beta binding agent | 2.0 | Recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | Beta-thalassemia | Transforming growth factor beta inhibitor | 2.0 | Completed | ClinicalTrials |
| LUSPATERCEPT | Protein | Beta-thalassemia | Transforming growth factor beta inhibitor | 3.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | head and neck squamous cell carcinoma | Transforming growth factor beta binding agent | 1.0 | Completed | ClinicalTrials |
| FRESOLIMUMAB | Antibody | focal segmental glomerulosclerosis | Transforming growth factor beta-1 inhibitor | 2.0 | Completed | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | metastatic malignant neoplasm | Transforming growth factor beta binding agent | 1.0 | Active, not recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | metastatic prostate cancer | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | neoplasm | Transforming growth factor beta binding agent | 1.0 | Completed | ClinicalTrials |
| FRESOLIMUMAB | Antibody | breast cancer | Transforming growth factor beta-1 inhibitor | 2.0 | Completed | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | breast carcinoma | Transforming growth factor beta binding agent | 1.0 | Terminated | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | anus cancer | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | anemia (phenotype) | Transforming growth factor beta inhibitor | 1.0 | Completed | ClinicalTrials |
| LY-2382770 | Antibody | diabetic nephropathy | Transforming growth factor beta-1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| LUSPATERCEPT | Protein | Beta-thalassemia | Transforming growth factor beta inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | Beta-thalassemia | Transforming growth factor beta inhibitor | 2.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | oropharynx cancer | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | prostate carcinoma | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | bladder transitional cell carcinoma | Transforming growth factor beta binding agent | 2.0 | Not yet recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | pancreatic carcinoma | Transforming growth factor beta binding agent | 1.0 | Terminated | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | non-small cell lung carcinoma | Transforming growth factor beta binding agent | 1.0 | Completed | ClinicalTrials |
| LUSPATERCEPT | Protein | Thalassemia | Transforming growth factor beta inhibitor | 4.0 | - | DailyMed |
| BINTRAFUSP ALFA | Protein | vulva cancer | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | myelodysplastic syndrome | Transforming growth factor beta inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | Kaposi's sarcoma | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | prostate cancer | Transforming growth factor beta binding agent | 2.0 | Not yet recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | myelodysplastic syndrome | Transforming growth factor beta inhibitor | 3.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | esophageal carcinoma | Transforming growth factor beta binding agent | 2.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | breast cancer | Transforming growth factor beta binding agent | 1.0 | Terminated | ClinicalTrials |
| LUSPATERCEPT | Protein | anemia (phenotype) | Transforming growth factor beta inhibitor | 4.0 | - | ATC |
| BINTRAFUSP ALFA | Protein | neoplasm | Transforming growth factor beta binding agent | 1.0 | Active, not recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | Aplastic anemia | Transforming growth factor beta inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | head and neck squamous cell carcinoma | Transforming growth factor beta binding agent | 2.0 | Terminated | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | prostate cancer | Transforming growth factor beta binding agent | 2.0 | Recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | myelodysplastic syndrome | Transforming growth factor beta inhibitor | 4.0 | - | DailyMed |
| FRESOLIMUMAB | Antibody | diffuse scleroderma | Transforming growth factor beta-1 inhibitor | 1.0 | Completed | ClinicalTrials |
| FRESOLIMUMAB | Antibody | renal cell carcinoma | Transforming growth factor beta-1 inhibitor | 1.0 | Completed | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | breast neoplasm | Transforming growth factor beta binding agent | 2.0 | Completed | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | non-small cell lung carcinoma | Transforming growth factor beta binding agent | 3.0 | Active, not recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | cervical cancer | Transforming growth factor beta binding agent | 1.0 | Active, not recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | breast cancer | Transforming growth factor beta binding agent | 1.0 | Active, not recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | non-small cell lung carcinoma | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| FRESOLIMUMAB | Antibody | idiopathic pulmonary fibrosis | Transforming growth factor beta-1 inhibitor | 1.0 | Completed | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | colorectal adenocarcinoma | Transforming growth factor beta binding agent | 2.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | cervical cancer | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | anemia (phenotype) | Transforming growth factor beta inhibitor | 2.0 | Completed | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | mesothelioma | Transforming growth factor beta binding agent | 2.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | urogenital neoplasm | Transforming growth factor beta binding agent | 2.0 | Terminated | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | vaginal cancer | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | small cell lung carcinoma | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | anemia | Transforming growth factor beta inhibitor | 4.0 | - | DailyMed |
| BINTRAFUSP ALFA | Protein | lung cancer | Transforming growth factor beta binding agent | 3.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | neoplasm | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| FRESOLIMUMAB | Antibody | brain neoplasm | Transforming growth factor beta-1 inhibitor | 2.0 | Completed | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | ovarian cancer | Transforming growth factor beta binding agent | 1.0 | Not yet recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | intrahepatic cholangiocarcinoma | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | cervical adenocarcinoma | Transforming growth factor beta binding agent | 2.0 | Active, not recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | cholangiocarcinoma | Transforming growth factor beta binding agent | 2.0 | Terminated | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | malignant colon neoplasm | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | gastric cancer | Transforming growth factor beta binding agent | 1.0 | Not yet recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | pancreatic adenocarcinoma | Transforming growth factor beta binding agent | 1.0 | Terminated | ClinicalTrials |
| LUSPATERCEPT | Protein | Myelodysplastic/Myeloproliferative Neoplasm | Transforming growth factor beta inhibitor | 2.0 | Recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | myelodysplastic syndrome | Transforming growth factor beta inhibitor | 2.0 | Completed | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | Thymoma | Transforming growth factor beta binding agent | 2.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | breast carcinoma | Transforming growth factor beta binding agent | 1.0 | Completed | ClinicalTrials |
| LUSPATERCEPT | Protein | Beta-thalassemia | Transforming growth factor beta inhibitor | 3.0 | Completed | ClinicalTrials |
| LUSPATERCEPT | Protein | myelodysplastic syndrome | Transforming growth factor beta inhibitor | 2.0 | Recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | myelodysplastic syndrome | Transforming growth factor beta inhibitor | 1.0 | Recruiting | ClinicalTrials |
| BINTRAFUSP ALFA | Protein | penile cancer | Transforming growth factor beta binding agent | 1.0 | Recruiting | ClinicalTrials |
| LUSPATERCEPT | Protein | myelodysplastic syndrome | Transforming growth factor beta inhibitor | 3.0 | Completed | ClinicalTrials |